Global Tuberculosis Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tuberculosis Therapeutics Market Size 2017-2028

2.1.2 Tuberculosis Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Tuberculosis Therapeutics Segment by Type

2.2.1 Isoniazid

2.2.2 Rifampin

2.2.3 Pyrazinamide

2.2.4 Hydrazine Derivatives

2.2.5 Miscellaneous Anti-Tubercular Drugs

2.2.6 Ethambutol

2.2.7 Others

2.3 Tuberculosis Therapeutics Market Size by Type

2.3.1 Tuberculosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Tuberculosis Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Tuberculosis Therapeutics Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Clinics

2.4.4 Others

2.5 Tuberculosis Therapeutics Market Size by Application

2.5.1 Tuberculosis Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Tuberculosis Therapeutics Market Size Market Share by Application (2017-2022)

3 Tuberculosis Therapeutics Market Size by Player

3.1 Tuberculosis Therapeutics Market Size Market Share by Players

3.1.1 Global Tuberculosis Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Tuberculosis Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Tuberculosis Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Tuberculosis Therapeutics by Regions

4.1 Tuberculosis Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Tuberculosis Therapeutics Market Size Growth (2017-2022)

4.3 APAC Tuberculosis Therapeutics Market Size Growth (2017-2022)

4.4 Europe Tuberculosis Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Tuberculosis Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Tuberculosis Therapeutics Market Size by Country (2017-2022)

5.2 Americas Tuberculosis Therapeutics Market Size by Type (2017-2022)

5.3 Americas Tuberculosis Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tuberculosis Therapeutics Market Size by Region (2017-2022)

6.2 APAC Tuberculosis Therapeutics Market Size by Type (2017-2022)

6.3 APAC Tuberculosis Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Tuberculosis Therapeutics by Country (2017-2022)

7.2 Europe Tuberculosis Therapeutics Market Size by Type (2017-2022)

7.3 Europe Tuberculosis Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tuberculosis Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Tuberculosis Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Tuberculosis Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Tuberculosis Therapeutics Market Forecast

10.1 Global Tuberculosis Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Tuberculosis Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Tuberculosis Therapeutics Forecast

10.1.3 APAC Tuberculosis Therapeutics Forecast

10.1.4 Europe Tuberculosis Therapeutics Forecast

10.1.5 Middle East & Africa Tuberculosis Therapeutics Forecast

10.2 Americas Tuberculosis Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Tuberculosis Therapeutics Market Forecast

10.2.2 Canada Tuberculosis Therapeutics Market Forecast

10.2.3 Mexico Tuberculosis Therapeutics Market Forecast

10.2.4 Brazil Tuberculosis Therapeutics Market Forecast

10.3 APAC Tuberculosis Therapeutics Forecast by Region (2023-2028)

10.3.1 China Tuberculosis Therapeutics Market Forecast

10.3.2 Japan Tuberculosis Therapeutics Market Forecast

10.3.3 Korea Tuberculosis Therapeutics Market Forecast

10.3.4 Southeast Asia Tuberculosis Therapeutics Market Forecast

10.3.5 India Tuberculosis Therapeutics Market Forecast

10.3.6 Australia Tuberculosis Therapeutics Market Forecast

10.4 Europe Tuberculosis Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Tuberculosis Therapeutics Market Forecast

10.4.2 France Tuberculosis Therapeutics Market Forecast

10.4.3 UK Tuberculosis Therapeutics Market Forecast

10.4.4 Italy Tuberculosis Therapeutics Market Forecast

10.4.5 Russia Tuberculosis Therapeutics Market Forecast

10.5 Middle East & Africa Tuberculosis Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Tuberculosis Therapeutics Market Forecast

10.5.2 South Africa Tuberculosis Therapeutics Market Forecast

10.5.3 Israel Tuberculosis Therapeutics Market Forecast

10.5.4 Turkey Tuberculosis Therapeutics Market Forecast

10.5.5 GCC Countries Tuberculosis Therapeutics Market Forecast

10.6 Global Tuberculosis Therapeutics Forecast by Type (2023-2028)

10.7 Global Tuberculosis Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Aventis Pharmaceuticals

11.1.1 Aventis Pharmaceuticals Company Information

11.1.2 Aventis Pharmaceuticals Tuberculosis Therapeutics Product Offered

11.1.3 Aventis Pharmaceuticals Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Aventis Pharmaceuticals Main Business Overview

11.1.5 Aventis Pharmaceuticals Latest Developments

11.2 Sanofi -Aventis

11.2.1 Sanofi -Aventis Company Information

11.2.2 Sanofi -Aventis Tuberculosis Therapeutics Product Offered

11.2.3 Sanofi -Aventis Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi -Aventis Main Business Overview

11.2.5 Sanofi -Aventis Latest Developments

11.3 Versapharma Incorporated

11.3.1 Versapharma Incorporated Company Information

11.3.2 Versapharma Incorporated Tuberculosis Therapeutics Product Offered

11.3.3 Versapharma Incorporated Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Versapharma Incorporated Main Business Overview

11.3.5 Versapharma Incorporated Latest Developments

11.4 Sigma Pharmaceutical Pty

11.4.1 Sigma Pharmaceutical Pty Company Information

11.4.2 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product Offered

11.4.3 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sigma Pharmaceutical Pty Main Business Overview

11.4.5 Sigma Pharmaceutical Pty Latest Developments

11.5 Novartis AG

11.5.1 Novartis AG Company Information

11.5.2 Novartis AG Tuberculosis Therapeutics Product Offered

11.5.3 Novartis AG Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Novartis AG Main Business Overview

11.5.5 Novartis AG Latest Developments

11.6 Hoffmann-La Roche

11.6.1 Hoffmann-La Roche Company Information

11.6.2 Hoffmann-La Roche Tuberculosis Therapeutics Product Offered

11.6.3 Hoffmann-La Roche Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Hoffmann-La Roche Main Business Overview

11.6.5 Hoffmann-La Roche Latest Developments

11.7 Bayer Health Care

11.7.1 Bayer Health Care Company Information

11.7.2 Bayer Health Care Tuberculosis Therapeutics Product Offered

11.7.3 Bayer Health Care Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Bayer Health Care Main Business Overview

11.7.5 Bayer Health Care Latest Developments

12 Research Findings and Conclusion

Table 1. Tuberculosis Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Isoniazid

Table 3. Major Players of Rifampin

Table 4. Major Players of Pyrazinamide

Table 5. Major Players of Hydrazine Derivatives

Table 6. Major Players of Miscellaneous Anti-Tubercular Drugs

Table 7. Major Players of Ethambutol

Table 8. Major Players of Others

Table 9. Tuberculosis Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Tuberculosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 11. Global Tuberculosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 12. Tuberculosis Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Tuberculosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 14. Global Tuberculosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 15. Global Tuberculosis Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 16. Global Tuberculosis Therapeutics Revenue Market Share by Player (2020-2022)

Table 17. Tuberculosis Therapeutics Key Players Head office and Products Offered

Table 18. Tuberculosis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 19. New Products and Potential Entrants

Table 20. Mergers & Acquisitions, Expansion

Table 21. Global Tuberculosis Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 22. Global Tuberculosis Therapeutics Market Size Market Share by Regions (2017-2022)

Table 23. Americas Tuberculosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 24. Americas Tuberculosis Therapeutics Market Size Market Share by Country (2017-2022)

Table 25. Americas Tuberculosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 26. Americas Tuberculosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 27. Americas Tuberculosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 28. Americas Tuberculosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 29. APAC Tuberculosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 30. APAC Tuberculosis Therapeutics Market Size Market Share by Region (2017-2022)

Table 31. APAC Tuberculosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 32. APAC Tuberculosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 33. APAC Tuberculosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 34. APAC Tuberculosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 35. Europe Tuberculosis Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 36. Europe Tuberculosis Therapeutics Market Size Market Share by Country (2017-2022)

Table 37. Europe Tuberculosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 38. Europe Tuberculosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 39. Europe Tuberculosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 40. Europe Tuberculosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 41. Middle East & Africa Tuberculosis Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Tuberculosis Therapeutics Market Size Market Share by Region (2017-2022)

Table 43. Middle East & Africa Tuberculosis Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Tuberculosis Therapeutics Market Size Market Share by Type (2017-2022)

Table 45. Middle East & Africa Tuberculosis Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Tuberculosis Therapeutics Market Size Market Share by Application (2017-2022)

Table 47. Key Market Drivers & Growth Opportunities of Tuberculosis Therapeutics

Table 48. Key Market Challenges & Risks of Tuberculosis Therapeutics

Table 49. Key Industry Trends of Tuberculosis Therapeutics

Table 50. Global Tuberculosis Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 51. Global Tuberculosis Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 52. Global Tuberculosis Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 53. Global Tuberculosis Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 54. Global Tuberculosis Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 55. Global Tuberculosis Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 56. Aventis Pharmaceuticals Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 57. Aventis Pharmaceuticals Tuberculosis Therapeutics Product Offered

Table 58. Aventis Pharmaceuticals Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 59. Aventis Pharmaceuticals Main Business

Table 60. Aventis Pharmaceuticals Latest Developments

Table 61. Sanofi -Aventis Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 62. Sanofi -Aventis Tuberculosis Therapeutics Product Offered

Table 63. Sanofi -Aventis Main Business

Table 64. Sanofi -Aventis Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Sanofi -Aventis Latest Developments

Table 66. Versapharma Incorporated Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 67. Versapharma Incorporated Tuberculosis Therapeutics Product Offered

Table 68. Versapharma Incorporated Main Business

Table 69. Versapharma Incorporated Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Versapharma Incorporated Latest Developments

Table 71. Sigma Pharmaceutical Pty Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 72. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product Offered

Table 73. Sigma Pharmaceutical Pty Main Business

Table 74. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Sigma Pharmaceutical Pty Latest Developments

Table 76. Novartis AG Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 77. Novartis AG Tuberculosis Therapeutics Product Offered

Table 78. Novartis AG Main Business

Table 79. Novartis AG Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Novartis AG Latest Developments

Table 81. Hoffmann-La Roche Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 82. Hoffmann-La Roche Tuberculosis Therapeutics Product Offered

Table 83. Hoffmann-La Roche Main Business

Table 84. Hoffmann-La Roche Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Hoffmann-La Roche Latest Developments

Table 86. Bayer Health Care Details, Company Type, Tuberculosis Therapeutics Area Served and Its Competitors

Table 87. Bayer Health Care Tuberculosis Therapeutics Product Offered

Table 88. Bayer Health Care Main Business

Table 89. Bayer Health Care Tuberculosis Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Bayer Health Care Latest Developments

List of Figures

Figure 1. Tuberculosis Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Tuberculosis Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Tuberculosis Therapeutics Market Size Market Share by Type in 2021

Figure 7. Tuberculosis Therapeutics in Hospital

Figure 8. Global Tuberculosis Therapeutics Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Tuberculosis Therapeutics in Pharmacy

Figure 10. Global Tuberculosis Therapeutics Market: Pharmacy (2017-2022) & ($ Millions)

Figure 11. Tuberculosis Therapeutics in Clinics

Figure 12. Global Tuberculosis Therapeutics Market: Clinics (2017-2022) & ($ Millions)

Figure 13. Tuberculosis Therapeutics in Others

Figure 14. Global Tuberculosis Therapeutics Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Tuberculosis Therapeutics Market Size Market Share by Application in 2021

Figure 16. Global Tuberculosis Therapeutics Revenue Market Share by Player in 2021

Figure 17. Global Tuberculosis Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Tuberculosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. APAC Tuberculosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Europe Tuberculosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Tuberculosis Therapeutics Market Size 2017-2022 ($ Millions)

Figure 22. Americas Tuberculosis Therapeutics Value Market Share by Country in 2021

Figure 23. Americas Tuberculosis Therapeutics Consumption Market Share by Type in 2021

Figure 24. Americas Tuberculosis Therapeutics Market Size Market Share by Application in 2021

Figure 25. United States Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Tuberculosis Therapeutics Market Size Market Share by Region in 2021

Figure 30. APAC Tuberculosis Therapeutics Market Size Market Share by Application in 2021

Figure 31. China Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Tuberculosis Therapeutics Market Size Market Share by Country in 2021

Figure 38. Europe Tuberculosis Therapeutics Market Size Market Share by Type in 2021

Figure 39. Europe Tuberculosis Therapeutics Market Size Market Share by Application in 2021

Figure 40. Germany Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Tuberculosis Therapeutics Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Tuberculosis Therapeutics Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Tuberculosis Therapeutics Market Size Market Share by Application in 2021

Figure 48. Egypt Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Tuberculosis Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. APAC Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Europe Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. United States Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Canada Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. China Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Japan Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Korea Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. India Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Australia Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Germany Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. France Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. UK Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Italy Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Russia Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Spain Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. Israel Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Tuberculosis Therapeutics Market Size 2023-2028 ($ Millions)